[go: up one dir, main page]

SG11202107901QA - Isolated cell culture components and methods for isolating the same from liquid cell culture medium - Google Patents

Isolated cell culture components and methods for isolating the same from liquid cell culture medium

Info

Publication number
SG11202107901QA
SG11202107901QA SG11202107901QA SG11202107901QA SG11202107901QA SG 11202107901Q A SG11202107901Q A SG 11202107901QA SG 11202107901Q A SG11202107901Q A SG 11202107901QA SG 11202107901Q A SG11202107901Q A SG 11202107901QA SG 11202107901Q A SG11202107901Q A SG 11202107901QA
Authority
SG
Singapore
Prior art keywords
cell culture
isolating
methods
same
culture medium
Prior art date
Application number
SG11202107901QA
Inventor
Deborah Lee Bitterfield
Michael Quinn DOHERTY
Original Assignee
Lindy Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lindy Biosciences Inc filed Critical Lindy Biosciences Inc
Publication of SG11202107901QA publication Critical patent/SG11202107901QA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/10—Separation or concentration of fermentation products
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/06—Hydrolysis; Cell lysis; Extraction of intracellular or cell wall material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02—Separating microorganisms from their culture media
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/08—Homogenizing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12—Purification

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Sustainable Development (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG11202107901QA 2019-02-05 2020-02-05 Isolated cell culture components and methods for isolating the same from liquid cell culture medium SG11202107901QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962801225P 2019-02-05 2019-02-05
PCT/US2020/016743 WO2020163446A1 (en) 2019-02-05 2020-02-05 Isolated cell culture components and methods for isolating the same from liquid cell culture medium

Publications (1)

Publication Number Publication Date
SG11202107901QA true SG11202107901QA (en) 2021-08-30

Family

ID=71947933

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202107901QA SG11202107901QA (en) 2019-02-05 2020-02-05 Isolated cell culture components and methods for isolating the same from liquid cell culture medium

Country Status (9)

Country Link
US (2) US20220119760A1 (en)
EP (1) EP3921082A4 (en)
JP (2) JP2022519690A (en)
KR (1) KR20210125032A (en)
CN (1) CN113661006A (en)
AU (2) AU2020219125B2 (en)
CA (1) CA3128204C (en)
SG (1) SG11202107901QA (en)
WO (1) WO2020163446A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4545070A3 (en) 2016-11-22 2025-06-18 Elektrofi, Inc Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
US11077059B2 (en) 2017-07-25 2021-08-03 Elektrofi, Inc. Electrospraying formation of particles including agents
US12115262B2 (en) 2018-05-24 2024-10-15 Elektrofi, Inc. Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
EP3921082A4 (en) 2019-02-05 2022-11-02 Lindy Biosciences, Inc. ISOLATED CELL CULTURE COMPONENTS AND METHODS OF ISOLATION THEREOF FROM LIQUID CELL CULTURE MEDIUM
WO2021212019A1 (en) 2020-04-17 2021-10-21 Elektrofi, Inc. Methods of forming particles by continuous droplet formation and dehydration
CN112675935B (en) * 2021-01-22 2022-03-25 中国科学院上海微系统与信息技术研究所 Droplet array chip for single cell freezing and droplet generation method and application
CN120813342A (en) * 2023-02-20 2025-10-17 林迪生物科学公司 Hyaluronidase particles, compositions comprising the same, and methods of making and using the same

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030143659A1 (en) * 1996-03-28 2003-07-31 Hendrik Louis Bijl Process for the preparation of a granular microbial biomass and isolation of a compound thereform
IN184589B (en) 1996-10-16 2000-09-09 Alza Corp
US6080844A (en) * 1998-04-23 2000-06-27 Abbott Laboratories Process for the recovery and purification of a recombinant protein from a cell
GB9910975D0 (en) 1999-05-13 1999-07-14 Univ Strathclyde Rapid dehydration of proteins
JP2003033195A (en) * 2001-07-24 2003-02-04 Kyowa Hakko Kogyo Co Ltd Method for producing tetrahydrocurcumin
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
AU2003299795A1 (en) 2002-12-20 2004-07-22 Xeris Pharmaceuticals, Inc. Intracutaneous injection
US20050186183A1 (en) * 2003-12-08 2005-08-25 Deangelo Joseph Stabilized products, processes and devices for preparing same
CA2566075A1 (en) * 2004-05-12 2005-12-01 Baxter Healthcare S.A. Microspheres comprising protein and showing injectability at high concentrations of said agent
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
US20060141040A1 (en) 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
JP2009521931A (en) * 2005-12-29 2009-06-11 アントフロゲネシス コーポレーション Improved composition for collecting and storing placental stem cells and methods of using the composition
MX2009003661A (en) 2006-10-06 2009-04-22 Baxter Int Microencapsules containing surface-modified microparticles and methods of forming and using the same.
US20090022727A1 (en) 2007-01-26 2009-01-22 Alza Corp. Injectable, nonaqueous suspension with high concentration of therapeutic agent
CN104000779A (en) 2007-04-23 2014-08-27 精达制药公司 Suspension formulations of insulinotropic peptides and uses thereof
GB0707938D0 (en) 2007-04-25 2007-05-30 Univ Strathclyde Precipitation stabilising compositions
EP2157096B1 (en) * 2007-05-17 2013-02-20 Waseda University Amphipathic molecule, molecular aggregate comprising the amphipathic molecule, and use of the molecular aggregate
WO2009005709A1 (en) 2007-06-28 2009-01-08 Surmodics, Inc. Polypeptide microparticles
US8598378B2 (en) 2008-03-14 2013-12-03 University Of Hawaii Methods and compositions for extraction and transesterification of biomass components
US20100009007A1 (en) 2008-07-10 2010-01-14 Baxter International Inc. Non-covalent modification of microparticles and process of preparing same
SI2341905T2 (en) 2008-09-04 2024-02-29 Amylin Pharmaceuticals, Llc Sustained release formulations using non-aqueous carriers
EP2349200A1 (en) 2008-10-15 2011-08-03 Intarcia Therapeutics, Inc Highly concentrated drug particles, formulations, suspensions and uses thereof
JP5711138B2 (en) 2008-11-16 2015-04-30 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム High concentration low viscosity suspension
EP2403483B1 (en) 2009-03-02 2017-05-10 Assistance Publique Hôpitaux De Paris Injectable biomaterial
PL3199511T3 (en) * 2009-06-04 2020-05-18 Genomatica, Inc. Process of separating components of a fermentation broth
US20110223208A1 (en) 2010-03-09 2011-09-15 Beth Hill Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
US9072668B2 (en) 2010-03-09 2015-07-07 Janssen Biotech, Inc. Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
MX2012011555A (en) * 2010-04-06 2013-01-29 Heliae Dev Llc Methods of and systems for isolating carotenoids and omega- 3 rich oils from algae.
US8308951B1 (en) * 2010-04-06 2012-11-13 Heliae Development, Llc Extraction of proteins by a two solvent method
WO2012012460A1 (en) 2010-07-19 2012-01-26 Xeris Pharmaceuticals, Inc. Stable glucagon formulations for the treatment of hypoglycemia
KR101978527B1 (en) 2011-03-10 2019-09-03 엑스에리스 파머수티클스, 인크. Stable formulations for parenteral injection of peptide drugs
CA2853942C (en) 2011-10-31 2020-08-25 Xeris Pharmaceuticals, Inc. Formulations for the treatment of diabetes
US9643996B2 (en) 2011-11-04 2017-05-09 Battelle Memorial Institute Processes for producing protein microparticles
GB201122408D0 (en) * 2011-12-23 2012-02-08 Univ Strathclyde Method for preparing dry protein formulations
SG11201407512VA (en) 2012-05-18 2014-12-30 Genentech Inc High-concentration monoclonal antibody formulations
KR101870174B1 (en) * 2013-05-31 2018-06-22 아이하트 재팬 가부시키가이샤 Layered cell sheet incorporating hydrogel
PT107846B (en) * 2014-08-01 2019-03-22 Hovione Farm S A Production of Amorphous Solid Dispersion Nanoparticles by Controlled Co-Precipitation
US11077059B2 (en) 2017-07-25 2021-08-03 Elektrofi, Inc. Electrospraying formation of particles including agents
EP3459529A1 (en) 2017-09-20 2019-03-27 Tillotts Pharma Ag Preparation of sustained release solid dosage forms comprising antibodies by spray drying
US12115262B2 (en) 2018-05-24 2024-10-15 Elektrofi, Inc. Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
EP3921082A4 (en) 2019-02-05 2022-11-02 Lindy Biosciences, Inc. ISOLATED CELL CULTURE COMPONENTS AND METHODS OF ISOLATION THEREOF FROM LIQUID CELL CULTURE MEDIUM
EP4027978A1 (en) * 2019-09-13 2022-07-20 Elektrofi, Inc. Compositions and methods for the delivery of therapeutic biologics for treatment of disease
WO2021212019A1 (en) 2020-04-17 2021-10-21 Elektrofi, Inc. Methods of forming particles by continuous droplet formation and dehydration

Also Published As

Publication number Publication date
AU2020219125A1 (en) 2021-08-12
US20230093954A1 (en) 2023-03-30
AU2025237973A1 (en) 2025-10-16
EP3921082A4 (en) 2022-11-02
AU2020219125B2 (en) 2025-10-02
KR20210125032A (en) 2021-10-15
EP3921082A1 (en) 2021-12-15
US11795429B2 (en) 2023-10-24
US20220119760A1 (en) 2022-04-21
JP2025026925A (en) 2025-02-26
JP2022519690A (en) 2022-03-24
CA3128204C (en) 2025-06-10
CA3128204A1 (en) 2020-08-13
WO2020163446A1 (en) 2020-08-13
CN113661006A (en) 2021-11-16

Similar Documents

Publication Publication Date Title
SG11202107901QA (en) Isolated cell culture components and methods for isolating the same from liquid cell culture medium
IL286907B2 (en) Cryopreservation and cell culture media
EP3739037A4 (en) Cell culturing method and device
IL282901A (en) Methods for isolating and expanding cells
EP3263697A4 (en) Culture medium for culturing mesenchymal stem cell, method for culturing mesenchymal stem cell, and mesenchymal stem cell
EP3860627A4 (en) Methods for the expansion of mesenchymal stromal cells
EP3743121A4 (en) Cell culturing device and method
SG11202012278XA (en) Cell culture system and cell culture method
SG11202106565WA (en) Media and methods for differentiating natural killer cells
IL282876A (en) Methods for isolating and expanding cells
EP3830248A4 (en) Methods for gene modification of hematopoietic cells
EP4051109A4 (en) Methods for the characterization of fluid
SG11202108227RA (en) Method and apparatus for isolating desired cells from suspensions with non-magnetic biological materials
EP3653696A4 (en) Cell culture vessel
EP3885428A4 (en) Perfusion culture apparatus and centrifugal separator
PT3877499T (en) Cell culture system and method
IL314599A (en) Cell culture methods
PL3436568T3 (en) Culture medium for pluripotent stem cells
EP3964560A4 (en) Cell culturing system
GB201909144D0 (en) Culture medium
EP3765044A4 (en) Methods for treating non-cancerous disorders using hematopoietic cells
GB201722186D0 (en) Methods and systems for the culture of cells at liquid-liquid interfaces
EP3990610A4 (en) Cell culture system
EP3988636A4 (en) Cell culture device
SG11202111135PA (en) Cell culture media comprising keto acids